Hella Emobionics Private Limited, a active private limited company, was established on 22 October 2020 in Delhi, Delhi, India. Engaging in auto parts & components within the manufacturing sector, it holds CIN: U35999DL2020PTC372004. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹40.00 Cr.
Employing 43 professional, Its leadership includes Naveen Gautam (Managing Director), Joerg Koelker Wilhelm (Director), Guido Schutte (Director). Past directors included Naveen Gautam, Anil Sultan, Detlev Boekenkamp Walter. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at K 61B , Basement Kalkaji, New Delhi, Delhi, Delhi, 110019.
U35999DL2020PTC372004
372004
22 October 2020
₹40.00 Cr
₹40.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Hella Emobionics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Gautam | Managing Director | 22 Oct 2020 | Current |
| Joerg Koelker Wilhelm | Director | 18 Jan 2021 | Current |
| Guido Schutte | Director | 12 Sep 2024 | Current |
| Sebastian Willi Nikolaus Keils | Additional Director | 13 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Nov 2020 | Past |
| Pramod Abcsdd | Director | 17 May 2021 | Past |
| Pramod Abcsdd | Director | 31 Dec 2023 | Past |
| Pramod Abcsdd | Director | 22 May 2025 | Past |
| Pramod Abcsdd | Additional Director | 11 Jun 2025 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hella Emobionics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.32% increase. The company also saw a substantial fall in profitability, with a 185.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Hella Emobionics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Hella Emobionics has a workforce of 43 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hella Emobionics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hella Emobionics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sebastian Willi Nikolaus Keils was appointed as a Additional Director was appointed as a Additional Director on 13 Aug 2025 & has been associated with this company since 3 months 18 days . was documented.
Progress on Hella Emobionics Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records. was documented.
The activity Guido Schutte was appointed as a Director was appointed as a Director on 12 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Hella Emobionics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Joerg Koelker Wilhelm was appointed as a Director was appointed as a Director on 18 Jan 2021 & has been associated with this company since 4 years 10 months . was completed.
Progress on Naveen Gautam was appointed as a Managing Director was appointed as a Managing Director on 22 Oct 2020 & has been associated with this company since 5 years 1 month . was documented.
The CIN of Hella Emobionics Private Limited is U35999DL2020PTC372004.
Hella Emobionics Private Limited is headquartered at K 61B , Basement Kalkaji, New Delhi, Delhi, Delhi, 110019.
Hella Emobionics Private Limited was incorporated on 22 October 2020.
The current directors of Hella Emobionics Private Limited are
The primary industry of Hella Emobionics Private Limited is Manufacturing.
Hella Emobionics Private Limited is unlisted.
The authorized capital of Hella Emobionics Private Limited is ₹40.00 Cr, and the paid-up capital is ₹40.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX